Who Comprises The Leadership Of ATHN?

The ATHN Board of Directors is comprised of a prestigious and broad based group of healthcare professionals and other leaders. The present ATHN Board of Directors reflects the broader hemostasis and thrombosis community with representation of consumers, providers and HTC regions. Seven of its 17 members are physicians providing care as pediatric or adult hematologists. Included are the immediate past president and a current board member of the Hemostasis and Thrombosis Research Society (HTRS), as well as a former chair of the National Hemophilia Foundation’s Medical and Scientific Advisory Council (MASAC), the professional body that recommends standards of care. Other ATHN board directors are drawn from different regions of the country to bring insight and expertise from clinical nursing, social services, law, and the management of treatment centers. A consumer member and the ATHN CEO complete the voting membership. In addition, to help ensure compatibility with the increasingly sophisticated public health network dedicated to bleeding and clotting disorders, a well respected hematologist represents the Centers for Disease Control and Prevention (CDC) Division of Blood Disorders as an ex officio member. The Co-chairs of the ATHN Board of Directors are:

Jeanne Lusher, M.D.
Co-Chair, ATHN Board of Directors
Director,
Hemostasis and Thrombosis Center;
Co-Director
Hematology / Oncology
Children's Hospital of Michigan
Distinguished Professor of Pediatrics,
Wayne State University
Detroit, MI

Amy Shapiro, M.D.
Co-Chair, ATHN Board of Directors
Medical Director
Indiana Hemophilia and Thrombosis Center
Indianapolis, IN